1Y Target$172.81Near-term target
5Y Target$214.13Compound horizon
10Y Target$273.32Long-dated conviction
FCF$1.4bTTM · 03/26C+FCF $1.4b — respectable but not differentiating · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+2.3%TTM YoYCRevenue +2.3% — flat, mature phase or headwinds present · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E9.32totalFD/E 9.32 — extreme leverage (may reflect buyback-driven equity depletion; verify FCF strength) · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/E14.5xB+P/E 14.5 — at or below S&P median, reasonable
PEG6.29proxyDPEG 6.29 — very expensive; pricing in best-case scenarios · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Technology · market cap $10.7b. Down 64% from 52-week high of $447.07 — deep drawdown territory.
Moat
ROE 120% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which.
Risk
D/E 9.32 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Down 64% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $172.81 (structural (no analyst coverage)) — multiple re-rating thesis requires a catalyst. 5 yr $214.13 at ~6% CAGR — dividend + buyback compounding. 10 yr $273.32 if the moat survives secular pressure.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.